Net shares · 365d
-21.3K
0 buy · 21.3K sell
Net value · 365d
-$3.9M
$0 in · $3.9M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
5
0 buy · 21.3K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
DGX Sell·S
SVP, Clinical Solutions · 10b5-1
$1.6M
8.1K sh · $200.00
Own -38%
-
DGX Sell·S
SVP, Clinical Solutions
$538.4K
2.6K sh · $204.86
Own -16%
-
DGX Sell·S
SVP, Clinical Solutions · 10b5-1
$1.8M
10.5K sh · $167.95 avg · 3 lots
Own -55%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | DGX | Sell S | 8.1K | $1.6M |
| Mar 4, 2026 | DGX | Sell S | 2.6K | $538.4K |
| Jul 31, 2025 | DGX | Sell S | 10.5K3 lots | $1.8M |
Buy Sell Non-market (grant · exercise · gift)
About KUPPUSAMY KARTHIK
This profile aggregates every SEC Form 4 insider transaction reported by KUPPUSAMY KARTHIK across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.